Dihydrobenzodiazepins and their use for treating dyslipidemia

Details Dihydrobenzodiazepins and their use for treating dyslipidemia Dihydrobenzodiazepins and their use for treating dyslipidemia

2008-01-29

2008-01-29

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S497000, C540S498000

Reexamination Certificate

active

07323458

ABSTRACT:
The invention concerns a benzodiazepin derivative of formula (I) and their use for treating dyslipidemia, atherosclerosis, diabetes and its complications.

REFERENCES:
patent: 3780023 (1973-12-01), Suh et al.
patent: 4554273 (1985-11-01), Bayssat et al.
patent: 5260339 (1993-11-01), Martin et al.
patent: 2540871 (1984-08-01), None
patent: 2 550 199 (1985-02-01), None
patent: 182884 (1983-06-01), None
patent: WO 9605188 (1996-02-01), None
Linda L. Setescak et al: “4-Aryl-4, 5-Dihydro-3H-1, 3-Benzodiazepines.3. 2-Phenyl and 2-Amino Analogues as Potential Antihypertensive Agents” Journal of Medicinal Chemistry., vol. 27, No. 3,—1984 pp. 401-404.
Timothy Jen et al.: “Amiidines. 4. Synthesis of Tricyclic Guanidines Related to 1,2,3,5-Tetrahydroimidazo(2,1-B)Quinazolin E, A New Antihypertensive Agent” Journal of Medicinal Chemistry., vol. 16, No. 4-1973 pp. 407-411.

Affiliated with

Also associated with

Rating

Dihydrobenzodiazepins and their use for treating dyslipidemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydrobenzodiazepins and their use for treating dyslipidemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrobenzodiazepins and their use for treating dyslipidemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2804061